Igor S Lukashevich has a long-standing research interest in molecular biology, pathogenesis and prevention of diseases caused by Hemorrhagic Fever Viruses (HFVs). He has extensive experience with HFVs from his field work in West Africa and from his experimental work with Lassa, Machupo, Marburg, and Ebola viruses in high biocontainment facilities. He has more than 100 publications in this area. His recent research program has focused on Lassa fever pathogenesis and vaccine R&D. He designed and developed experimental reassortants ML29 and YF17D-based Lassa fever experimental vaccines. In collaboration with Dr. S Paessler (UTMB) and Dr. Juan C de la Torre (Scripps Res. Inst.), he is developing recombinant ML29 as a vaccine platform to control HFVs in African countries. Igor S Lukashevich has a long-standing research interest in molecular biology, pathogenesis and prevention of diseases caused by Hemorrhagic Fever Viruses (HFVs). He has extensive experience with HFVs from his field work in West Africa and from his experimental work with Lassa, Machupo, Marburg, and Ebola viruses in high biocontainment facilities. He has more than 100 publications in this area. His recent research program has focused on Lassa fever pathogenesis and vaccine R&D. He designed and developed experimental reassortants ML29 and YF17D-based Lassa fever experimental vaccines. In collaboration with Dr. S Paessler (UTMB) and Dr. Juan C de la Torre (Scripps Res. Inst.), he is developing recombinant ML29 as a vaccine platform to control HFVs in African countries.

virology, vaccination and veterinary sciences